Annual EBIT
-$69.35 M
-$25.42 M-57.88%
December 31, 2023
Summary
- As of February 8, 2025, IMCR annual earnings before interest & taxes is -$69.35 million, with the most recent change of -$25.42 million (-57.88%) on December 31, 2023.
- During the last 3 years, IMCR annual EBIT has risen by +$38.78 million (+35.86%).
- IMCR annual EBIT is now -57.88% below its all-time high of -$43.93 million, reached on December 31, 2022.
Performance
IMCR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
$9.87 M
+$16.24 M+255.07%
September 30, 2024
Summary
- As of February 8, 2025, IMCR quarterly earnings before interest & taxes is $9.87 million, with the most recent change of +$16.24 million (+255.07%) on September 30, 2024.
- Over the past year, IMCR quarterly EBIT has increased by +$34.20 million (+140.57%).
- IMCR quarterly EBIT is now at all-time high.
Performance
IMCR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$41.67 M
+$7.82 M+15.80%
September 30, 2024
Summary
- As of February 8, 2025, IMCR TTM earnings before interest & taxes is -$41.67 million, with the most recent change of +$7.82 million (+15.80%) on September 30, 2024.
- Over the past year, IMCR TTM EBIT has increased by +$14.07 million (+25.24%).
- IMCR TTM EBIT is now -16.80% below its all-time high of -$35.67 million, reached on March 31, 2023.
Performance
IMCR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
IMCR EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -57.9% | +140.6% | +25.2% |
3 y3 years | +35.9% | +123.8% | +74.8% |
5 y5 years | +40.5% | +123.8% | +74.8% |
IMCR EBIT Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -57.9% | +71.1% | at high | +122.6% | -16.8% | +76.4% |
5 y | 5-year | -57.9% | +71.1% | at high | +120.7% | -16.8% | +76.4% |
alltime | all time | -57.9% | +71.1% | at high | +120.7% | -16.8% | +76.4% |
Immunocore Holdings EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $9.87 M(-255.1%) | -$41.67 M(-15.8%) |
Jun 2024 | - | -$6.37 M(-69.5%) | -$49.49 M(-15.7%) |
Mar 2024 | - | -$20.84 M(-14.4%) | -$58.67 M(+5.3%) |
Dec 2023 | -$69.35 M(+57.9%) | -$24.33 M(-1285.8%) | -$55.73 M(+15.2%) |
Sep 2023 | - | $2.05 M(-113.2%) | -$48.39 M(+12.8%) |
Jun 2023 | - | -$15.55 M(-13.2%) | -$42.88 M(+20.2%) |
Mar 2023 | - | -$17.91 M(+5.4%) | -$35.67 M(-9.4%) |
Dec 2022 | -$43.93 M | -$16.99 M(-324.7%) | -$39.37 M(-40.4%) |
Sep 2022 | - | $7.56 M(-190.6%) | -$66.07 M(-42.6%) |
Jun 2022 | - | -$8.34 M(-61.4%) | -$115.17 M(-25.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | -$21.61 M(-50.5%) | -$154.56 M(-12.6%) |
Dec 2021 | -$239.80 M(+121.8%) | -$43.68 M(+5.1%) | -$176.74 M(+7.0%) |
Sep 2021 | - | -$41.55 M(-13.0%) | -$165.14 M(+7.8%) |
Jun 2021 | - | -$47.73 M(+9.0%) | -$153.25 M(+17.5%) |
Mar 2021 | - | -$43.79 M(+36.5%) | -$130.47 M(+15.8%) |
Dec 2020 | -$108.13 M(-30.8%) | -$32.07 M(+8.2%) | -$112.66 M(-11.1%) |
Sep 2020 | - | -$29.65 M(+18.8%) | -$126.75 M(+30.5%) |
Jun 2020 | - | -$24.95 M(-3.9%) | -$97.10 M(+34.6%) |
Mar 2020 | - | -$25.98 M(-43.7%) | -$72.14 M(+56.3%) |
Dec 2019 | -$156.28 M(+34.1%) | -$46.16 M | -$46.16 M |
Dec 2018 | -$116.53 M | - | - |
FAQ
- What is Immunocore Holdings annual earnings before interest & taxes?
- What is the all time high annual EBIT for Immunocore Holdings?
- What is Immunocore Holdings annual EBIT year-on-year change?
- What is Immunocore Holdings quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Immunocore Holdings?
- What is Immunocore Holdings quarterly EBIT year-on-year change?
- What is Immunocore Holdings TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Immunocore Holdings?
- What is Immunocore Holdings TTM EBIT year-on-year change?
What is Immunocore Holdings annual earnings before interest & taxes?
The current annual EBIT of IMCR is -$69.35 M
What is the all time high annual EBIT for Immunocore Holdings?
Immunocore Holdings all-time high annual earnings before interest & taxes is -$43.93 M
What is Immunocore Holdings annual EBIT year-on-year change?
Over the past year, IMCR annual earnings before interest & taxes has changed by -$25.42 M (-57.88%)
What is Immunocore Holdings quarterly earnings before interest & taxes?
The current quarterly EBIT of IMCR is $9.87 M
What is the all time high quarterly EBIT for Immunocore Holdings?
Immunocore Holdings all-time high quarterly earnings before interest & taxes is $9.87 M
What is Immunocore Holdings quarterly EBIT year-on-year change?
Over the past year, IMCR quarterly earnings before interest & taxes has changed by +$34.20 M (+140.57%)
What is Immunocore Holdings TTM earnings before interest & taxes?
The current TTM EBIT of IMCR is -$41.67 M
What is the all time high TTM EBIT for Immunocore Holdings?
Immunocore Holdings all-time high TTM earnings before interest & taxes is -$35.67 M
What is Immunocore Holdings TTM EBIT year-on-year change?
Over the past year, IMCR TTM earnings before interest & taxes has changed by +$14.07 M (+25.24%)